I guess the way I look at it as, ABL + standard of care ( that being a Statin, GLT2i, DPP4i ).
I was not sure if tada meant a combination of small molecules (in a single pill form) in his original post, which would limit one only SGLT2 inhibitor, hence one PH, i.e, Jardiance (LLY).
Koo